Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo

[1]  Beppie van den Bogaerde,et al.  Clinical practice , 2011, European Journal of Pediatrics.

[2]  Arthur Kornberg,et al.  Inorganic polyphosphate: essential for growth and survival. , 2009, Annual review of biochemistry.

[3]  O. McCarty,et al.  Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. , 2009, Blood.

[4]  M. Ponczek,et al.  Evolution of the contact phase of vertebrate blood coagulation , 2008, Journal of thrombosis and haemostasis : JTH.

[5]  J. Morrissey,et al.  Polyphosphate as a general procoagulant agent , 2008, Journal of thrombosis and haemostasis : JTH.

[6]  B. Zuraw.  Clinical practice. Hereditary angioedema. , 2008, The New England journal of medicine.

[7]  C. Maas,et al.  Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. , 2008, The Journal of clinical investigation.

[8]  A. Schmaier.  The elusive physiologic role of Factor XII. , 2008, The Journal of clinical investigation.

[9]  T. Renné,et al.  Novel roles for factor XII-driven plasma contact activation system , 2008, Current opinion in hematology.

[10]  B. Furie,et al.  Mechanisms of thrombus formation. , 2008, The New England journal of medicine.

[11]  D. Wagner,et al.  The vessel wall and its interactions. , 2008, Blood.

[12]  D. Tanné,et al.  Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. , 2008, Blood.

[13]  N. Mackman.  Triggers, targets and treatments for thrombosis , 2008, Nature.

[14]  T. Renné,et al.  Intrinsic Pathway of Coagulation and Arterial Thrombosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[15]  James H Morrissey,et al.  Polyphosphate enhances fibrin clot structure. , 2007, Blood.

[16]  James H Morrissey,et al.  Sensitive fluorescence detection of polyphosphate in polyacrylamide gels using 4′,6‐diamidino‐2‐phenylindol , 2007, Electrophoresis.

[17]  T. Renné,et al.  The intrinsic pathway of coagulation: a target for treating thromboembolic disease? , 2007, Journal of thrombosis and haemostasis : JTH.

[18]  B. Jilma,et al.  Evidence of a U‐shaped association between factor XII activity and overall survival , 2007, Journal of thrombosis and haemostasis : JTH.

[19]  K. Preissner,et al.  Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation , 2007, Proceedings of the National Academy of Sciences.

[20]  C. Weber,et al.  Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease , 2007, Circulation research.

[21]  D. Seiffert,et al.  Effects of factor XI deficiency on ferric chloride‐induced vena cava thrombosis in mice , 2006, Journal of thrombosis and haemostasis : JTH.

[22]  T. Renné,et al.  Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis , 2006, The Journal of experimental medicine.

[23]  James H Morrissey,et al.  Polyphosphate modulates blood coagulation and fibrinolysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Renné,et al.  Defective thrombus formation in mice lacking coagulation factor XII , 2005, The Journal of experimental medicine.

[25]  大房 健.  基礎講座 電気泳動(Electrophoresis) , 2005 .

[26]  Hui Zhang,et al.  Platelet activation leads to activation and propagation of the complement system , 2005, The Journal of experimental medicine.

[27]  F. Marceau,et al.  International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences , 2005, Pharmacological Reviews.

[28]  E. Oldfield,et al.  Human Platelet Dense Granules Contain Polyphosphate and Are Similar to Acidocalcisomes of Bacteria and Unicellular Eukaryotes* , 2004, Journal of Biological Chemistry.

[29]  T. Renné,et al.  Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo , 2004, Thrombosis and Haemostasis.

[30]  Zaverio M. Ruggeri,et al.  Platelets in atherothrombosis , 2002, Nature Medicine.

[31]  A. Davis,et al.  Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. , 2002, The Journal of clinical investigation.

[32]  E. Kuehl,et al.  Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). , 1998, The New England journal of medicine.

[33]  L. Björck,et al.  Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases , 1998, Nature Medicine.

[34]  A. Kornberg,et al.  Inorganic Polyphosphate in Mammalian Cells and Tissues (*) , 1995, The Journal of Biological Chemistry.

[35]  M. Silverberg,et al.  Activation of the classical pathway of complement by Hageman factor fragment , 1981, The Journal of experimental medicine.

[36]  A. Mangal,et al.  HAGEMAN FACTOR DEFICIENCY AND ORAL CONTRACEPTIVES , 1980, The Lancet.

[37]  R. Sheon,et al.  The Demise of John Hageman , 1968 .

[38]  J. Caen,et al.  Availability of Platelet Factor 3 and Activation of Factor XII in Thrombasthenia , 1965, Nature.

[39]  O. Ratnoff,et al.  A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. , 1955, The Journal of clinical investigation.

[40]  G. Glaeske,et al.  Ambulante Hämophilie-Behandlung im Krankenhaus – Aktueller Stand der gesetzlichen Grundlagen für Versorgungsverträge , 2009 .

[41]  T. Renné,et al.  Local Bradykinin Formation Is Controlled by Glycosaminoglycans , 2005 .

[42]  J. Griffin,et al.  Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. , 1981, Blood.